Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jim Lupski, Katherine Rauen

Premium

Baylor College of Medicine's Jim Lupski has received the 2014 Environmental Mutagenesis and Genomics Society Award in recognition of his work in characterizing human mutations and linking them to disease.

Lupski, a professor of molecular and human genetics at BCM, has relied on chromosomal microarrays and whole-genome sequencing to discover several disease genes, including the first gene for Charcot-Marie Tooth syndrome.

EMGS recognizes one researcher each year for outstanding research contributions in the area of environmental mutagenesis and genomics. Lupski will receive the award on Sept. 16 at the society's annual meeting in Orlando, Fla.


Katherine Rauen was among the 102 recipients of the Presidential Early Career Awards for Scientists and Engineers, an honor bestowed by the US government on science and engineering professionals in the early stages of their independent research careers.

Rauen is a medical geneticist an adjunct professor at the University of California, San Francisco's department of pediatrics and recently accepted a position at UC Davis' department of pediatrics. She is being recognized for her work in studying Ras/MAPK pathway genetics syndromes. Rauen is also internationally recognized for her work in array comparative genomic hybridization.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.